BIOMEA FUSION INC (BMEA) Stock News

USA - Nasdaq - NASDAQ:BMEA - US09077A1060 - Common Stock

1.01 USD

+0.03 (+2.85%)

Last: 11/24/2025, 8:00:02 PM

1.0199 USD

+0.01 (+0.98%)

After Hours: 11/24/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BMEA Latest News, Press Relases and Analysis

All

Press Releases

19 hours ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate at Upcoming Investor Conferences

19 hours ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate at Upcoming Investor Conferences

15 days ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate at Jefferies London Healthcare Conference

20 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025

20 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025

20 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights

20 days ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights

26 days ago - By: Biomea Fusion, Inc.

Biomea Fusion to Present Poster Presentations at ObesityWeek®2025

26 days ago - By: Biomea Fusion, Inc.

Biomea Fusion to Present Poster Presentations at ObesityWeek®2025

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

a month ago - By: Biomea Fusion, Inc.

Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series

2 months ago - By: Benzinga - Mentions: SNWV CLRB APVO SPRB ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

2 months ago - By: Benzinga

Biomea Fusion Stock Plummets Following Public Offering, Diabetes Study

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Pricing of Public Offering of Securities

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Pricing of Public Offering of Securities

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Proposed Public Offering of Securities

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Proposed Public Offering of Securities

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

2 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

3 months ago - By: Yahoo Finance - Mentions: UBS WYNN DB TIC ...

Five Below upgraded, Bill downgraded: Wall Street's top analyst calls

4 months ago - By: The Motley Fool

Biomea Fusion (BMEA) Q2 Loss Drops 44%

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Appoints Julianne Averill to its Board of Directors

4 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Appoints Julianne Averill to its Board of Directors

5 months ago - By: Biomea Fusion, Inc.

Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA)